Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Terbinafine for Toenail Onychomycosis
NCT00443898Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of Terbinafine in onychomycosis, sponsored by Novartis. Started Dec 2006; status: completed.
02
Drugs
Terbinafine
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT00443898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00443898.